Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China
· Delayed Price · Currency is CNY 30.50
+1.96 (6.87%)
At close: Mar 9, 2026
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 12.37 billion as of March 9, 2026. Its market cap has increased by 168.81% in one year.
Market Cap
12.37B
Enterprise Value
12.56B
Revenue
704.16M
Ranking
n/a
PE Ratio
556.60
Stock Price
30.50
Market Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 12.37B, a decrease of -23.48%. That is a compound annual growth rate of -5.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 11.58B | 12.48% |
| Dec 31, 2025 | 10.29B | 139.25% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hualan Biological Vaccine | 11.55B |
| Beijing Hotgen Biotech | 11.90B |
| Staidson (Beijing) BioPharmaceuticals | 12.35B |
| Chengzhi | 10.85B |
| InventisBio | 12.37B |
| HitGen | 10.83B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 10.70B |
| Vcanbio Cell & Gene Engineering Corp., | 12.81B |